Bypass Graft Angiography & PCI: A Complete Radiation-Safe Protocol for LIMA, RIMA & SVG

1. Introduction

Bypass graft angiography remains a cornerstone of post-CABG surveillance and recurrent ischemia workup in the contemporary cardiac catheterization laboratory. Following coronary artery bypass grafting, approximately 15–20% of saphenous vein grafts occlude within the first year, while left internal mammary artery grafts maintain superior long-term patency exceeding 90% at 10 years.[1] When recurrent angina or non-invasive ischemia testing suggests graft dysfunction, invasive angiography provides the definitive anatomical assessment and enables percutaneous coronary intervention when feasible.

The technical complexity of bypass graft angiography exceeds native coronary catheterization. Graft ostia arise from non-anatomical locations—the ascending aorta, subclavian arteries, or prior graft-to-graft anastomoses—requiring operators to master specific engagement angles and selective catheter shapes. Moreover, these procedures often involve prolonged fluoroscopy times and multiple cine acquisitions, elevating radiation exposure for both patients and laboratory personnel.[2] Implementing projection-optimized, dose-minimized protocols is therefore essential for safe, efficient practice.

2. Understanding bypass graft anatomy and angiographic targets

Coronary artery bypass grafting employs three principal conduit types, each with distinct anatomical courses and angiographic signatures. The left internal mammary artery originates from the left subclavian artery, coursing anterior to the pulmonary artery hilum before anastomosing to the left anterior descending artery or its diagonal branch. The right internal mammary artery arises similarly from the right subclavian, typically crossing the midline to reach the LAD or diagonal territory when used in situ, or remaining in situ for right coronary or circumflex targets.[3]

Saphenous vein grafts represent the most commonly used secondary conduits. Aortocoronary SVGs are anastomosed to the anterior or anterolateral ascending aorta, with distal connections to the LAD, diagonal, obtuse marginal, or posterior descending arteries. The precise location of proximal anastomoses varies by surgeon preference and aortic pathology; calcified ascending aortas may necessitate composite graft configurations or proximal anastomoses to mammary artery pedicles rather than direct aortic attachment.[4]

Understanding these anatomical variations is fundamental to successful bypass graft angiography. The operator must anticipate graft origin locations based on operative reports and surgical clips visible on fluoroscopy. Prior sternotomy wires and mediastinal clips serve as radiographic landmarks, while graft markers—small metallic rings placed at proximal anastomoses—further facilitate rapid localization during catheter engagement.

3. Optimal C-arm projections for bypass graft angiography

Successful visualization of bypass grafts depends on selecting projections that align the X-ray beam parallel to the graft course while minimizing tissue attenuation. Unlike native coronaries, graft origins are not fixed anatomically; therefore, a systematic approach combining shallow neutral angles with selective cranial or caudal tilt optimizes opacification and reduces radiation dose.

Left internal mammary artery and right internal mammary artery grafts

Mammary artery grafts present unique engagement challenges due to their subclavian origins and anterior mediastinal courses. The standard working projection combines anteroposterior with 20° cranial angulation, which profiles the LIMA/RIMA origin off the subclavian and separates the graft body from the sternal wires and mediastinal clips. A shallow right anterior oblique at 10°–20° provides complementary visualization, particularly when the graft courses behind the sternum or when evaluating the distal anastomosis.

The lowest-dose approach utilizes pure AP (0°) or minimal RAO (10°) during initial wire traversal and catheter engagement. These neutral angles minimize thoracic tissue path length, reducing the automatic exposure control demand and consequent patient skin dose. Once the catheter is engaged, modest cranial angulation (10°–20°) can be applied for cine acquisition without substantially increasing dose-area product.

Saphenous vein graft to the left anterior descending artery

SVGs to the LAD or diagonal branches typically originate from the anterior ascending aorta and course over the right ventricular outflow tract. The optimal projection combines RAO 20°–30° with 15°–20° cranial angulation. This view elongates the graft body, separates it from the native LAD, and profiles the distal anastomosis without superimposition of the diaphragm or cardiac apex.

Saphenous vein graft to the circumflex territory

Grafts supplying obtuse marginal or posterolateral branches require LAO 35°–45° combined with 25°–30° caudal angulation. This projection tilts the X-ray beam beneath the heart, projecting the circumflex SVG away from the spine and native circumflex system. The caudal component is particularly critical in obese patients, where diaphragmatic overlap obscures distal graft segments in standard LAO views.

Saphenous vein graft to the right coronary artery

SVGs to the RCA or posterior descending artery are best visualized in LAO 30°–45° with minimal cranial or caudal tilt. Steeper LAO angulation opens the tricuspid plane, separating the graft from the right atrial border and facilitating assessment of the proximal anastomosis and mid-graft body. When evaluating the distal anastomosis to the posterior descending artery, additional cranial angulation (10°–15°) may be necessary to profile the vessel beyond the acute margin of the heart.

4. Radiation exposure settings and dose optimization

Percutaneous coronary intervention in bypass grafts consistently generates higher radiation exposure than native vessel PCI due to prolonged procedure times, complex engagement sequences, and the frequent need for multiple angulated acquisitions. The PROTECTION VIII registry demonstrated that a history of CABG is an independent predictor of increased dose-area product, with median DAP values exceeding 4,200 cGy·cm² in post-surgical cases.[1]

Standard adult protocols

For average-sized adults (body mass index 18.5–29.9 kg/m²), standard bypass graft angiography employs 70–90 kV tube potential with 50–150 mA tube current during fluoroscopy. Cineangiography requires higher output: 80–100 kV and 100–300 mA, depending on projection angulation and patient habitus. Pulsed fluoroscopy at 7.5 frames per second provides adequate temporal resolution for catheter manipulation while reducing dose by approximately 50% compared with standard 15 fps acquisition.[2]

Obese patient modifications

In obese patients (BMI ≥30 kg/m²), attenuation through the lateral chest wall and mediastinum necessitates substantial protocol adjustments. Tube potential increases to 95–120 kV, with cine currents ranging from 200 to 600+ mA. The automatic exposure control system will drive these parameters upward; however, operators should manually verify that peak skin dose does not approach 2 Gy, the threshold for deterministic injury. When feasible, steep angulations should be limited in obese patients, as lateral projections through expanded soft-tissue envelopes disproportionately increase entrance dose.

Additional dose-saving strategies include storing fluoroscopy loops for graft run documentation rather than performing repeated cine acquisitions, utilizing last-image hold for roadmap guidance, and applying tight collimation to exclude non-essential anatomy from the radiation field.[5]

5. Scatter radiation protection with SATPRO

Scatter radiation in the cardiac catheterization laboratory originates primarily from Compton interactions within the patient volume, with intensity peaking at 90° to the primary beam. During bypass graft procedures, the left anterior oblique projections used for circumflex and RCA SVG evaluation direct scatter toward the operator's left side, while steep cranial angles increase skull and thyroid exposure. Traditional lead aprons provide inadequate protection for the head, neck, and hands—anatomical sites where interventional cardiologists demonstrate elevated cumulative doses.[6]

SATPRO disposable bismuth drapes address this protection gap by attenuating scattered radiation at its source. Positioned over the patient's left chest wall and upper abdomen during LIMA engagement, or draped across the lower thorax during LAO projections, these lead-free shields absorb low-energy scatter before it reaches the operator. Clinical phantom studies demonstrate dose reductions of 29–70% at operator position, with bismuth-based nanomaterials providing equivalent attenuation to lead at substantially reduced weight.[7][8]

Proper placement is critical. The drape must cover the irradiated patient volume without encroaching on the image receptor field, as intrafield shielding can trigger automatic exposure compensation and paradoxically increase patient dose. For femoral access cases, the drape should extend from the xiphoid process to the pubic symphysis; for radial access, additional shielding across the right shoulder and upper arm protects against scatter from the subclavian engagement site. SATPRO integrates seamlessly with ceiling-mounted lead acrylic shields and under-table curtains, creating a multi-layered defense architecture.[9]

6. Procedural workflow and clinical pearls

Roadmapping and engagement techniques

Roadmapping—overlaying a stored contrast-enhanced image onto live fluoroscopy—dramatically reduces procedural time and contrast volume during bypass graft engagement. After initial contrast injection through a diagnostic catheter, the roadmap image is stored and displayed as a translucent overlay. The operator then advances a hydrophilic guidewire toward the graft ostium under roadmap guidance, avoiding repeated non-selective contrast puffs. This technique is particularly valuable for LIMA engagement, where the acute angle between the subclavian and internal mammary origins challenges standard wire-catheter combinations.

For aortocoronary SVGs, a multipurpose or Judkins right catheter typically engages proximal anastomoses located on the anterior aortic wall. When graft markers are present, roadmapping from a shallow LAO projection localizes the target; the catheter is then advanced with gentle clockwise rotation until it drops into the ostium. If engagement proves difficult, a balloon-tipped flotation catheter can be used to float into the graft origin from the ascending aorta.

Graft run acquisition strategies

Once selective engagement is achieved, cine acquisition should be performed in at least two orthogonal projections to characterize lesions fully. For LIMA grafts, AP-cranial and shallow RAO-cranial views provide complementary assessment of the body and distal anastomosis. SVGs require graft-specific projections as detailed previously. Contrast injection rates vary by graft caliber: 3–4 mL/s for mammary arteries, 4–6 mL/s for SVGs, with total volumes of 6–10 mL per run. Pressure monitoring during injection prevents graft dissection, particularly in degenerated, friable SVGs.

Percutaneous coronary intervention in bypass grafts

PCI in degenerated SVGs carries elevated risk of distal embolization and no-reflow due to the friable, atherosclerotic nature of vein graft plaque. Embolic protection devices—distal occlusion balloons, filters, or proximal occlusion systems—are indicated for SVG interventions and reduce periprocedural myocardial infarction rates. Drug-eluting stents demonstrate superior patency compared with bare-metal stents in SVG lesions, though restenosis rates remain higher than in native vessels. For LIMA graft stenosis, direct stenting with minimal predilation is preferred given the graft's resistance to dissection and propensity for spasm.[10]

7. Common pitfalls and complication avoidance

Several technical errors routinely complicate bypass graft angiography. Ostial trauma occurs when catheters are forcefully engaged against aortic or subclavian walls; this risk is magnified in SVGs with flush ostial anastomoses. Gentle catheter manipulation under roadmap guidance, combined with deep breathing commands to lower the heart and great vessels, facilitates safe engagement. Graft dissection results from high-pressure contrast injection into diseased or recently anastomosed grafts; always verify catheter position and pressure waveform before power injection.

No-reflow phenomenon affects 5–15% of SVG interventions and manifests as abrupt TIMI flow reduction despite patent epicardial vessels. Prevention strategies include embolic protection device deployment, slow contrast injection during diagnostic runs, and intragraft administration of vasodilators (adenosine, verapamil, or nitroprusside) before stent deployment. Contrast-induced nephropathy represents a cumulative risk in patients with pre-existing renal dysfunction who require multiple graft runs; limiting contrast volume to <300 mL total, ensuring adequate hydration, and using iso-osmolar contrast agents mitigate this risk.[11]

Radiation-induced skin injury, though rare in diagnostic angiography, becomes a concern during complex multigraft PCI with prolonged fluoroscopy. Peak skin dose should be monitored in real time, and procedures exceeding 60 minutes of fluoroscopy time or 3 Gy air kerma warrant post-procedure skin examination and documentation.

8. Conclusion

Mastering bypass graft angiography demands a systematic, anatomy-driven approach that balances diagnostic completeness with radiation safety. By selecting projection-specific C-arm angles for LIMA, RIMA, and SVG visualization, operators minimize both contrast volume and fluoroscopy time. Dose optimization through pulsed fluoroscopy, low-dose cine presets, and AEC-aware parameter selection protects patients across body habitus. The integration of SATPRO scatter-shielding drapes into routine workflow attenuates occupational exposure without compromising procedural efficiency. As CABG populations age and graft surveillance intervals shorten, adherence to these evidence-based protocols ensures that interventional cardiology teams deliver precise, safe, and sustainable care.

9. References

1. Stocker, T. J., et al. (2020). Trends and predictors of radiation exposure in percutaneous coronary intervention: The PROTECTION VIII study. EuroIntervention, 16(8), 663–671. https://doi.org/10.4244/EIJ-D-19-00945
2. Werner, G. S., et al. (2025). Improvement of radiation management in percutaneous coronary intervention. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.11.009
3. Gaudino, M., et al. (2023). Angiographic outcomes for arterial and venous conduits used in CABG. Journal of Clinical Medicine, 12(5), 2022. https://doi.org/10.3390/jcm12052022
4. Caliskan, E., et al. (2020). Saphenous vein grafts in contemporary coronary artery bypass graft surgery. Nature Reviews Cardiology, 17(3), 155–169. https://doi.org/10.1038/s41569-019-0249-3
5. Biso, S. M. R., et al. (2020). Radiation protection in the cardiac catheterization laboratory. Journal of Thoracic Disease, 12(1), 124–135. https://doi.org/10.21037/jtd.2019.12.58
6. Gutierrez-Barrios, A., et al. (2022). Radiation protection for the interventional cardiologist: Practical approach and innovations. World Journal of Cardiology, 14(1), 1–12. https://doi.org/10.4330/wjc.v14.i1.1
7. McCutcheon, K., et al. (2020). Efficacy of MAVIG X-Ray Protective Drapes in reducing operator radiation dose in the cardiac catheterization laboratory. Circulation: Cardiovascular Interventions, 13(11), e009627. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009627
8. McCutcheon, K., et al. (2021). Efficacy of MAVIG X-ray protective drapes in reducing CTO operator radiation. Journal of Interventional Cardiology, 2021, 3146104. https://doi.org/10.1155/2021/3146104
9. Medranda, G. A., et al. (2023). The impact of the RADPAD protection drape in reducing radiation exposure in a contemporary cardiac catheterization laboratory: Insights from the ATTENUATE trial. Journal of the Society for Cardiovascular Angiography & Interventions, 2(3), 100939. https://doi.org/10.1016/j.jscai.2023.100939
10. Xenogiannis, I., et al. (2021). Saphenous vein graft failure: From pathophysiology to prevention and treatment strategies. Circulation, 144(9), e131–e145. https://doi.org/10.1161/CIRCULATIONAHA.120.052163
11. Hall, A. B., & Brilakis, E. S. (2019). Saphenous vein graft failure: Seeing the bigger picture. Journal of Thoracic Disease, 11(Suppl 9), S1441–S1444. https://doi.org/10.21037/jtd.2019.03.09
12. Harik, L., et al. (2023). Choice of conduit for coronary artery bypass grafting: Technical, anatomic, and pharmacologic considerations. Vessel Plus, 7, 30. https://doi.org/10.20517/2574-1209.2023.124
13. Guida, G. A., & Angelini, G. D. (2022). Pathophysiology and mechanisms of saphenous vein graft failure. Brazilian Journal of Cardiovascular Surgery, 37(Spec 1), 32–37. https://doi.org/10.21470/1678-9741-2022-0133
14. Marcusohn, E., et al. (2018). Usefulness of pelvic radiation protection shields during transfemoral procedures. American Journal of Cardiology, 122(6), 1098–1103. https://doi.org/10.1016/j.amjcard.2018.06.003
15. Anadol, R., et al. (2020). Effectiveness of additional X-ray protection devices in reducing scattered radiation in radial intervention: The ESPRESSO randomised trial. EuroIntervention, 16(8), 663–671. https://doi.org/10.4244/EIJ-D-19-00945
16. Salcido-Rios, J., et al. (2022). Suspended lead suit and physician radiation doses during coronary angiography. Catheterization and Cardiovascular Interventions, 99(5), 981–988. https://doi.org/10.1002/ccd.30047
17. Gutierrez-Barrios, A., et al. (2021). The radioprotective effect of the Cathpax® AIR cabin during interventional cardiology procedures. Catheterization and Cardiovascular Interventions, 98(4), e29773. https://doi.org/10.1002/ccd.29773
18. Bang, J. Y., et al. (2020). Use of artificial intelligence to reduce radiation exposure at fluoroscopy-guided endoscopic procedures. American Journal of Gastroenterology, 115(4), 555–561. https://doi.org/10.14309/ajg.0000000000000565
19. Park, S. J., et al. (2020). Sequential versus individual saphenous vein grafting during coronary arterial bypass surgery. Annals of Thoracic Surgery, 109(4), 1165–1173. https://doi.org/10.1016/j.athoracsur.2019.09.041
20. Li, Y., et al. (2020). The patency of graft and anastomoses in sequential and individual coronary artery bypass grafting: A meta-analysis. Anatolian Journal of Cardiology, 24(4), 235–242. https://doi.org/10.5152/AnatolJCardiol.2020.3042
21. Samano, N., et al. (2015). The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. European Journal of Cardio-Thoracic Surgery, 48(5), 750–755. https://doi.org/10.1093/ejcts/ezu314
22. Kotoulas, S. C., et al. (2025). Radiation-free percutaneous coronary intervention. Journal of Clinical Medicine, 14(2), 412. https://doi.org/10.3390/jcm14020412
23. American College of Radiology. (2024). ACR manual on contrast media (2024 ed.). https://www.acr.org/-/media/ACR/Files/Clinical-Resources/Contrast_Media.pdf
24. International Commission on Radiological Protection. (2020). ICRP publication 147: Use of dosimetric quantities for regulatory purposes. Annals of the ICRP, 49(3), 1–19. https://doi.org/10.1177/0146645320911629
25. Neumann, F. J., et al. (2019). 2019 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal, 40(2), 87–165. https://doi.org/10.1093/eurheartj/ehz425
26. Dimagli, A., et al. (2023). Angiographic outcomes for arterial and venous conduits used in CABG. Journal of Clinical Medicine, 12(5), 2022. https://doi.org/10.3390/jcm12052022
27. Prapas, S. N., et al. (2020). Comparative outcomes of RIMA-SVG versus Ao-SVG configurations in coronary artery bypass grafting. Journal of Thoracic Disease, 12(Suppl 1), S56–S64. https://doi.org/10.21037/jtd.2019.12.45
28. Bousis, C. N. (2025). Patient radiation dose and contrast usage impacted by assisted coronary angiography technologies. Cardiology Journal, 32(1), 45–53. https://doi.org/10.5603/CJ.2025.0012